Literature DB >> 29644406

The Wessex modified Richmond Sedation Scale as a novel tool for monitoring patients at risk of malignant MCA syndrome.

Tayyib T A Hayat1, Matthew A Myers2, John Hell2, Matthew Cordingly2, Diederik O Bulters2, Nicolas Weir2, George Pengas2.   

Abstract

BACKGROUND: The Wessex Modified Richmond Sedation Scale (WMRSS) has been developed with the aim of improving the early identification of patients requiring decompressive hemicraniectomy for malignant middle cerebral artery syndrome (MMS). The objective of this study was to evaluate the WMRSS against the Glasgow Coma Scale (GCS).
METHODS: A retrospective study was conducted of patients admitted to our unit for observation of MMS. Data were obtained on WMRSS and GCS recordings from admission up to 120-h post-ictus. Patients' meeting inclusion criteria were recommended for theatre based on subsequent deteriorations in consciousness on either WMRSS or GCS from a 6-h post-stroke baseline, after ruling out non-neurological causes.
RESULTS: Approximately, 60% of those eligible for monitoring were not recommended for theatre, and none died; however, these patients continued to demonstrate some variability in recorded conscious level. Patients requiring surgical intervention showed earlier drops in WMRSS compared to GCS. Neither the GCS nor the WMRSS on admission predicted the subsequent need for decompressive surgery. There was no increase in mortality with the introduction of WMRSS.
CONCLUSIONS: WMRSS adds value to monitoring MMS by indicating need for surgery prior to GCS. Early reduction in consciousness may not be sufficient for proceeding to surgical intervention, but subsequent reduction in consciousness may be a more appropriate criterion for surgery.

Entities:  

Keywords:  Glasgow coma scale; Malignant MCA syndrome; Stroke

Mesh:

Year:  2018        PMID: 29644406     DOI: 10.1007/s00701-018-3531-y

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  17 in total

1.  A simple brain atrophy measure improves the prediction of malignant middle cerebral artery infarction by acute DWI lesion volume.

Authors:  Christoph Beck; Anna Kruetzelmann; Nils D Forkert; Eric Juettler; Oliver C Singer; Martin Köhrmann; Jan F Kersten; Jan Sobesky; Christian Gerloff; Jens Fiehler; Peter D Schellinger; Joachim Röther; Götz Thomalla
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

Authors:  W Hacke; S Schwab; M Horn; M Spranger; M De Georgia; R von Kummer
Journal:  Arch Neurol       Date:  1996-04

3.  Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns.

Authors:  T Heinsius; J Bogousslavsky; G Van Melle
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

Authors:  Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp
Journal:  Lancet Neurol       Date:  2009-03-05       Impact factor: 44.182

6.  Large hemispheric infarction, deterioration, and intracranial pressure.

Authors:  J I Frank
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

7.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

8.  Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS).

Authors:  E Wesley Ely; Brenda Truman; Ayumi Shintani; Jason W W Thomason; Arthur P Wheeler; Sharon Gordon; Joseph Francis; Theodore Speroff; Shiva Gautam; Richard Margolin; Curtis N Sessler; Robert S Dittus; Gordon R Bernard
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272

9.  Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion.

Authors:  Christian Foerch; Bettina Otto; Oliver C Singer; Tobias Neumann-Haefelin; Bernard Yan; Joachim Berkefeld; Helmuth Steinmetz; Matthias Sitzer
Journal:  Stroke       Date:  2004-08-05       Impact factor: 7.914

10.  Revisiting Hemicraniectomy: Late Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke and the Role of Infarct Growth Rate.

Authors:  Saadat Kamran; Naveed Akhtar; Abdul Salam; Ayman Alboudi; Kainat Kamran; Arsalan Ahmed; Rabia A Khan; Mohsin K Mirza; Jihad Inshasi; Ashfaq Shuaib
Journal:  Stroke Res Treat       Date:  2017-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.